Services

Histology

Pharmacology

Medical Device Testing

In Vitro Screening

Animal Model Development

Custom Assay Development

Vivarium Rental

Toxicology

Species

Non-human Primates

Dogs

Mini-pigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Career

Request a Quote

Logo
☰
  • Services ⌄
    • Histology
    • Pharmacology
    • Medical Device Testing
    • In Vitro Screening
    • Animal Model Development
    • Custom Assay Development
    • Vivarium Rental
    • Toxicology
  • Species ⌄
    • Non-human Primates
    • Dogs
    • Mini-pigs / Pigs
    • Rabbits
    • Mice
    • Rats
    • Sheep
    • Guinea Pigs
    • Hamsters
    • Other Species
  • Therapeutic Areas ⌄
    • Oncology
    • Immunology & Inflammation
    • Neurology / CNS
    • Cardiovascular
    • Dermatology & Wound Healing
    • Metabolism
    • Gastroenterology
    • Hepatology
    • Pulmonology
    • Infectious Diseases & Sepsis
    • Musculoskeletal
    • Nephrology & Urology
  • Capabilities ⌄
    • GLP / IND-Enabling Studies
    • Small and Large Animal Housing
    • Bioanalytical Platforms
  • About ⌄
    • News
  • Contact ⌄
    • Career
    • Request a Quote

Heptares Co-Founder Resigns as VP and CSO of Parent Company Sosei

  • Post author:Sam
  • Post published:January 18, 2018
  • Post category:BioPharma

Dr. Marshall will leave Sosei at the end of February 2018. Source: BioSpace

Continue ReadingHeptares Co-Founder Resigns as VP and CSO of Parent Company Sosei

What You Need to Know About Jecure Therapeutics

  • Post author:Sam
  • Post published:January 18, 2018
  • Post category:BioPharma

Jecure Therapeutics, based in San Diego, stated operations in mid-2016 with a focus on NASH and liver fibrosis. Source: BioSpace

Continue ReadingWhat You Need to Know About Jecure Therapeutics

Teva's Job Cuts Hit 208 Philadelphia Employees

  • Post author:Sam
  • Post published:January 18, 2018
  • Post category:BioPharma

The cuts are being made as the company grapples with a debt of between $30 and $35B and a restructuring of its R&D in order to combat dramatically declining revenue…

Continue ReadingTeva's Job Cuts Hit 208 Philadelphia Employees

Shire's Incoming Financial Head Honcho Finally Gets a Start Date

  • Post author:Sam
  • Post published:January 18, 2018
  • Post category:BioPharma

Shire will have its new CFO in March. Source: BioSpace

Continue ReadingShire's Incoming Financial Head Honcho Finally Gets a Start Date

This Cancer Drug Could Bring in $3.8B for AstraZeneca

  • Post author:Sam
  • Post published:January 18, 2018
  • Post category:BioPharma

The survey of 51 oncologists suggests broad uptake of Imfinzi in advanced lung cancer patients who can't be treated with surgery. Source: BioSpace

Continue ReadingThis Cancer Drug Could Bring in $3.8B for AstraZeneca

Booming Homology Inks Deal for Huge New Massachusetts HQ

  • Post author:Sam
  • Post published:January 17, 2018
  • Post category:BioPharma

Things are looking up for Massachusetts-based Homology Medicines. Source: BioSpace

Continue ReadingBooming Homology Inks Deal for Huge New Massachusetts HQ

What You Need to Know About CARMA Therapeutics

  • Post author:Sam
  • Post published:January 17, 2018
  • Post category:BioPharma

CARMA Therapeutics is based on technology from the Center for Cellular Immunotherapies at the University of Pennsylvania, and was spun out of the laboratory of Saar Gill, assistant professor of…

Continue ReadingWhat You Need to Know About CARMA Therapeutics

What Happens to the FDA if the Government Shuts Down

  • Post author:Sam
  • Post published:January 17, 2018
  • Post category:BioPharma

The agency would have to furlough about 45 percent of its staff. Source: BioSpace

Continue ReadingWhat Happens to the FDA if the Government Shuts Down

Why a Celgene-Juno Marriage Makes Perfect Sense

  • Post author:Sam
  • Post published:January 17, 2018
  • Post category:BioPharma

Investors and analysts have given it some thought and mostly think it's a sensible acquisition. Source: BioSpace

Continue ReadingWhy a Celgene-Juno Marriage Makes Perfect Sense

3 Broker Favorite Biopharmas Your Portfolio Must Have

  • Post author:Sam
  • Post published:January 17, 2018
  • Post category:BioPharma

These stocks have been given a Strong Buy or Buy rating by 80% or more brokers. Source: BioSpace

Continue Reading3 Broker Favorite Biopharmas Your Portfolio Must Have
  • Go to the previous page
  • 1
  • …
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • …
  • 288
  • Go to the next page

Stay Connected

Keep up with the latest news & insights.

Contact Us

Phone:
+1 858-605-5882
Fax:
+1 858-605-5916
Email:
info@biolegacyresearch.com
Mail:

6042 Cornerstone Court W

Suite E

San Diego, CA 92121

Social:
© 2025 BioLegacy Research. All rights reserved.